Oxeltis at the gordon conference 2025

For 15 years, Oxeltis has been your trusted partner for custom nucleos(t)ide synthesis and drug discovery programs. With more than 1,500 complex nucleos(t)ides synthesized – comprising prodrugs, phosphoramidites and triphosphates- containing extensive modifications to the sugar backbone, nucleobase and/or phosphoramidate moiety, we have developed a one-of-a-kind expertise.

Today, Oxeltis is proud to sponsor the 2025 GRC Nucleosides, Nucleotides, and Oligonucleotides conference which will be held in Newport, Rhode Island, July 6-11.

The attendance of Marie Hamann, Principal Research Scientist at Oxeltis and Nucleoside Expert, at this prestigious conference demonstrates our commitment to remaining at the forefront of the latest advances in this field.

#Nucleoside #Nucleotide #Oxeltis #GRC2025 #GordonResearchConference